Tags |
|
|
Links |
|
|
Main Subject - Federal Bankruptcy Laws
Federal bankruptcy laws are only for companies and firms that wish to file for bankruptcy, individuals cannot go for t
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
hese options. Chapter 11 and Chapter 7 are the two main categories of federal bankruptcy laws that businesses can cho
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ose from.
Chapter 11 provides the company or firm with an opportunity to rebuild the business in spite of crippling d
Chapter 11 provides the company or firm with an opportunity to rebuild the business in spite of crippling d
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ebts. The federal court plays an active part in such cases, as it has to give the approval for all the business decisi
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ons made once the case is filed. Chapter 11 is preferred to Chapter 7 because the company will not be closed to liquid
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ate its assets in this instance. Also, unlike in Chapter 7, the company does not become a security asset for lien and
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
can still be run as usual.
Like a trustee in Chapter 7 and Chapter 13 cases, the SEC plays an important role in Chapt
Like a trustee in Chapter 7 and Chapter 13 cases, the SEC plays an important role in Chapt
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
er 11. The SEC has to determine if the case is fraudulent and if the company or firm really needs to file the case ins
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
tead of just pretension for the benefit of the shareholders and investors. If the company is involved in trading after
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
it has filed for bankruptcy, then the details relating to such must be registered with the SEC.
The money will be re
The money will be re
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
paid to the creditors as decided by the law. Bondholders and investors with secured collateral are usually paid first.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
Stockholders will be paid only if the company is able to stand back on its feet and able to make some profits in spit
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
e of filing the bankruptcy case. However, they may continue to trade with their existing stock in the local stock mar
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ket unless the company liquidates these shares. Owners will be paid last after all the debt is returned to all the abo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ve-mentioned people involved with the company.
During bankruptcy, the company might not be able to provide the bondho
During bankruptcy, the company might not be able to provide the bondho
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
lders with principle and the stockholders with dividends, but they might try to make up for this by providing then wit
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
h new stock that they put on the market for regaining their stand. The stockholders might not even receive this if the
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
company has more liabilities than assets. A re-organization plan is prepared by a committee of creditors and stockhol
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ders of that company and of those appointed by the trustee to enable the company to buy more time while trying to get
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
on to its feet. This plan is reviewed by the SEC and then has to be approved by the court before being put into action
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/91195/mainsubjects-Federal-Bankruptcy-Laws.html">Federal Bankruptcy Laws</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/91195/mainsubjects-Federal-Bankruptcy-Laws.html]Federal Bankruptcy Laws[/url]
Related Articles:
Name That Customer Service Breakdown: Is It A Listening Problem or a Memory Problem?
14 Tips for Promoting Your Business with Postcards
New Bankruptcy Law Restrictions Lifted for Scores of Hurricane Victims
Bookmark it:
|